RS53999B1 - PIRIDIN HINOLIN SUBSTITUTED PIROLO [1,2-B] PIRAZOLE MONOHYDRATE AS TGF-BETA INHIBITOR - Google Patents
PIRIDIN HINOLIN SUBSTITUTED PIROLO [1,2-B] PIRAZOLE MONOHYDRATE AS TGF-BETA INHIBITORInfo
- Publication number
- RS53999B1 RS53999B1 RS20150319A RSP20150319A RS53999B1 RS 53999 B1 RS53999 B1 RS 53999B1 RS 20150319 A RS20150319 A RS 20150319A RS P20150319 A RSP20150319 A RS P20150319A RS 53999 B1 RS53999 B1 RS 53999B1
- Authority
- RS
- Serbia
- Prior art keywords
- pyridin
- inhibtor
- tgf
- beta
- substituted pyrrolo
- Prior art date
Links
- JUJGNTINMISJQF-UHFFFAOYSA-N O.C1=CNN2C=CC=C21 Chemical class O.C1=CNN2C=CC=C21 JUJGNTINMISJQF-UHFFFAOYSA-N 0.000 title 1
- UMHSKYSHOIGDPE-UHFFFAOYSA-N pyridine;quinoline Chemical group C1=CC=NC=C1.N1=CC=CC2=CC=CC=C21 UMHSKYSHOIGDPE-UHFFFAOYSA-N 0.000 title 1
- ZRKFYGHZFMAOKI-QMGMOQQFSA-N tgfbeta Chemical compound C([C@H](NC(=O)[C@H](C(C)C)NC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCSC)C(C)C)[C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](C)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N1[C@@H](CCC1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(O)=O)C1=CC=C(O)C=C1 ZRKFYGHZFMAOKI-QMGMOQQFSA-N 0.000 title 1
- -1 6-Methyl-pyridin-2-yl Chemical group 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Physical Education & Sports Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US70164105P | 2005-07-22 | 2005-07-22 | |
| PCT/US2006/025377 WO2007018818A1 (en) | 2005-07-22 | 2006-06-29 | A pyridin quinolin substituted pyrrolo [1,2-b] pyrazole monohydrate as tgf-beta inhibitor |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| RS53999B1 true RS53999B1 (en) | 2015-10-30 |
Family
ID=37450942
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| RS20150319A RS53999B1 (en) | 2005-07-22 | 2006-06-29 | PIRIDIN HINOLIN SUBSTITUTED PIROLO [1,2-B] PIRAZOLE MONOHYDRATE AS TGF-BETA INHIBITOR |
Country Status (16)
Families Citing this family (33)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AR081810A1 (es) | 2010-04-07 | 2012-10-24 | Bayer Cropscience Ag | Piridinilpirazoles biciclicos |
| CN103764655B (zh) * | 2011-07-13 | 2017-04-12 | Sk化学公司 | 作为alk5和／或alk4抑制剂的经2‑吡啶基取代的咪唑 |
| US20150289795A1 (en) | 2012-11-12 | 2015-10-15 | Institució Catalana De Recerca I Estudis Avançats | Methods and kits for the prognosis of colorectal cancer |
| WO2014159356A1 (en) | 2013-03-14 | 2014-10-02 | The Brigham And Women's Hospital, Inc. | Compositions and methods for epithelial stem cell expansion and culture |
| US10568883B2 (en) | 2014-09-03 | 2020-02-25 | Massachusetts Institute Of Technology | Compositions, systems, and methods for generating inner ear hair cells for treatment of hearing loss |
| WO2016123573A1 (en) | 2015-01-30 | 2016-08-04 | President And Fellows Of Harvard College | Peritumoral and intratumoral materials for cancer therapy |
| WO2016160881A1 (en) | 2015-04-01 | 2016-10-06 | Rigel Pharmaceuticals, Inc. | TGF-β INHIBITORS |
| US10669528B2 (en) | 2015-06-25 | 2020-06-02 | Children's Medical Center Corporation | Methods and compositions relating to hematopoietic stem cell expansion, enrichment, and maintenance |
| US10450318B2 (en) | 2015-12-15 | 2019-10-22 | Bristol-Myers Squibb Company | CXCR4 receptor antagonists |
| EP3400286A1 (en) | 2016-01-08 | 2018-11-14 | Massachusetts Institute Of Technology | Production of differentiated enteroendocrine cells and insulin producing cells |
| US10201540B2 (en) | 2016-03-02 | 2019-02-12 | Frequency Therapeutics, Inc. | Solubilized compositions for controlled proliferation of stem cells / generating inner ear hair cells using GSK3 inhibitors: I |
| US11260130B2 (en) | 2016-03-02 | 2022-03-01 | Frequency Therapeutics, Inc. | Solubilized compositions for controlled proliferation of stem cells / generating inner ear hair cells using a GSK3 inhibitor: IV |
| US10213511B2 (en) | 2016-03-02 | 2019-02-26 | Frequency Therapeutics, Inc. | Thermoreversible compositions for administration of therapeutic agents |
| WO2017161001A1 (en) | 2016-03-15 | 2017-09-21 | Children's Medical Center Corporation | Methods and compositions relating to hematopoietic stem cell expansion |
| WO2018006870A1 (zh) * | 2016-07-07 | 2018-01-11 | 苏州科睿思制药有限公司 | Galunisertib的晶型及其制备方法和用途 |
| JP2019534266A (ja) | 2016-10-14 | 2019-11-28 | 江蘇恒瑞医薬股▲ふん▼有限公司 | ５員ヘテロアリール環の架橋した環誘導体、その製造方法およびその医学的使用 |
| SG10201910821XA (en) | 2016-12-30 | 2020-01-30 | Frequency Therapeutics Inc | 1h-pyrrole-2,5-dione compounds and methods of using them to induce self-renewal of stem/progenitor supporting cells |
| CN110582497B (zh) * | 2017-03-17 | 2022-03-11 | 杭州领业医药科技有限公司 | Galunisertib的晶型及其制备方法和药物组合物 |
| WO2018170724A1 (zh) | 2017-03-21 | 2018-09-27 | 杭州领业医药科技有限公司 | 2-(6-甲基-吡啶-2-基)-3-基-[6-酰胺基-喹啉-4-基]-5,6-二氢-4H-吡咯并[1,2-b]吡唑的共晶，其制备方法和药物组合物 |
| WO2019042383A1 (zh) * | 2017-08-31 | 2019-03-07 | 苏州科睿思制药有限公司 | Galunisertib的晶型及其制备方法和用途 |
| WO2019105082A1 (zh) * | 2017-11-30 | 2019-06-06 | 苏州科睿思制药有限公司 | Galunisertib的晶型及其制备方法和用途 |
| WO2019137027A1 (zh) * | 2018-01-12 | 2019-07-18 | 苏州科睿思制药有限公司 | Galunisertib的晶型及其制备方法和用途 |
| CA3093340A1 (en) | 2018-03-20 | 2019-09-26 | Icahn School Of Medicine At Mount Sinai | Kinase inhibitor compounds and compositions and methods of use |
| US20210254006A1 (en) | 2018-06-06 | 2021-08-19 | Ideaya Biosciences, Inc. | Methods of culturing and/or expanding stem cells and/or lineage committed progenitor cells using lactam compounds |
| US11162071B2 (en) | 2018-08-17 | 2021-11-02 | Frequency Therapeutics, Inc. | Compositions and methods for generating hair cells by upregulating JAG-1 |
| US11617745B2 (en) | 2018-08-17 | 2023-04-04 | Frequency Therapeutics, Inc. | Compositions and methods for generating hair cells by downregulating FOXO |
| JP2022515652A (ja) | 2018-12-31 | 2022-02-21 | アイカーン スクール オブ メディシン アット マウント サイナイ | キナーゼ阻害剤化合物及び組成物ならびに使用方法 |
| CN115282280A (zh) * | 2022-08-12 | 2022-11-04 | 中国科学技术大学 | TGF-β1信号抑制剂的新用途 |
| WO2024229406A1 (en) | 2023-05-04 | 2024-11-07 | Revolution Medicines, Inc. | Combination therapy for a ras related disease or disorder |
| GB202309553D0 (en) | 2023-06-24 | 2023-08-09 | Ucl Business Ltd | Compostions and uses thereof |
| WO2025034702A1 (en) | 2023-08-07 | 2025-02-13 | Revolution Medicines, Inc. | Rmc-6291 for use in the treatment of ras protein-related disease or disorder |
| WO2025080946A2 (en) | 2023-10-12 | 2025-04-17 | Revolution Medicines, Inc. | Ras inhibitors |
| WO2025171296A1 (en) | 2024-02-09 | 2025-08-14 | Revolution Medicines, Inc. | Ras inhibitors |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2002094833A1 (en) | 2001-05-24 | 2002-11-28 | Eli Lilly And Company | Novel pyrrole derivatives as pharmaceutical agents |
| JP2006522735A (ja) * | 2002-11-21 | 2006-10-05 | イーライ リリー アンド カンパニー | ミックス系統キナーゼモジュレータ |
| UA80571C2 (en) * | 2002-11-22 | 2007-10-10 | Lilly Co Eli | Quinolinyl-pyrrolopyrazoles |
-
2006
- 2006-06-29 JP JP2008522796A patent/JP5242391B2/ja not_active Expired - Fee Related
- 2006-06-29 PL PL06774280T patent/PL1910370T3/pl unknown
- 2006-06-29 US US11/995,938 patent/US7872020B2/en not_active Expired - Fee Related
- 2006-06-29 HU HUE06774280A patent/HUE025209T2/en unknown
- 2006-06-29 DK DK06774280.9T patent/DK1910370T3/en active
- 2006-06-29 BR BRPI0613639-7A patent/BRPI0613639A2/pt not_active Application Discontinuation
- 2006-06-29 RS RS20150319A patent/RS53999B1/en unknown
- 2006-06-29 SI SI200631924T patent/SI1910370T1/sl unknown
- 2006-06-29 WO PCT/US2006/025377 patent/WO2007018818A1/en active Application Filing
- 2006-06-29 PT PT67742809T patent/PT1910370E/pt unknown
- 2006-06-29 MX MX2008001020A patent/MX2008001020A/es active IP Right Grant
- 2006-06-29 CA CA2616196A patent/CA2616196C/en not_active Expired - Fee Related
- 2006-06-29 ES ES06774280.9T patent/ES2542425T3/es active Active
- 2006-06-29 HR HRP20150474TT patent/HRP20150474T1/hr unknown
- 2006-06-29 EP EP20060774280 patent/EP1910370B1/en active Active
-
2007
- 2007-12-17 IL IL188181A patent/IL188181A/en not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| HUE025209T2 (en) | 2016-03-29 |
| CA2616196C (en) | 2012-08-21 |
| US7872020B2 (en) | 2011-01-18 |
| JP2009502780A (ja) | 2009-01-29 |
| EP1910370A1 (en) | 2008-04-16 |
| IL188181A (en) | 2014-05-28 |
| BRPI0613639A2 (pt) | 2012-02-22 |
| JP5242391B2 (ja) | 2013-07-24 |
| MX2008001020A (es) | 2008-03-25 |
| SI1910370T1 (sl) | 2015-06-30 |
| HRP20150474T1 (xx) | 2015-06-05 |
| PT1910370E (pt) | 2015-06-30 |
| IL188181A0 (en) | 2008-03-20 |
| PL1910370T3 (pl) | 2015-09-30 |
| WO2007018818A1 (en) | 2007-02-15 |
| DK1910370T3 (en) | 2015-06-08 |
| EP1910370B1 (en) | 2015-04-22 |
| CA2616196A1 (en) | 2007-02-15 |
| US20100120854A1 (en) | 2010-05-13 |
| ES2542425T3 (es) | 2015-08-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| RS53999B1 (en) | PIRIDIN HINOLIN SUBSTITUTED PIROLO [1,2-B] PIRAZOLE MONOHYDRATE AS TGF-BETA INHIBITOR | |
| IL278119B (en) | Disubstituted pyrazolo[5.1–a]pyrimidine compounds as trk kinase inhibitors | |
| NO2014006I1 (no) | Vemurafenib. Propan-l-sulfonsyre3-[5-(4-klorfenyl)-lH-pyrrolo[2,3-b]pyridin-3-karbonyl]-2,4-difluor-fenyl-amid | |
| SI1966202T1 (sl) | S heteroarilom substituirani pirolo (2,3-b)piridini in pirolo (2,3-b)pirimidini kot zaviralci janus kinaze | |
| PL1904494T3 (pl) | Związki imidazo[1,2-A]pirydynowe jako inhibitory VEGF-R2 | |
| SI1697356T1 (sl) | Pirido(2,3-d)pirimidin-2,4-diamini kot zaviralci PDE 2 | |
| AP2453A (en) | Pyrazolo(3,4-B) pyridine derivatives as phosphodiesterase inhibitors | |
| CY1116567T1 (el) | ΕΝΑ ΠΥΡΙΔΙΝΟΚΙΝΟΛΙΝΟ-ΥΠΟΚΑΣΤΕΣΤΗΜΕΝΟ ΜΟΝΟΕΝΥΔΡΟ ΠΥΡΡΟΛΟ [1,2-B]ΠΥΡΑΖΟΛΙΟ ΩΣ ΑΝΑΣΤΟΛΕΑΣ ΤΟΥ TGF-β | |
| HK1138515A (en) | Pyrazolo[3,4-b]pyridine derivatives as phosphodiesterase inhibitors | |
| HK1137177A (en) | Novel heteroaryl substituted imidazo [1,2 -a] pyridine derivatives | |
| HK1108880A (en) | 1,4 substituted pyrazolopyrimidines as kinase inhibitors |